RESEARCH AT THE MAGOEBAS ULTRA

2022 Research Study Information

Please read through the study information provided below before you arrive at race registration.

STUDY TITLE: The epidemiology, clinical characteristics and associated injury risk factors among trail runners entered for the 2023 Magoebas Forest Marathon

 

Principal Investigators:  Carel Viljoen, Christa Janse van Rensburg, Tanita Cronje

Institution: University of Pretoria

 

DAYTIME AND AFTER HOURS TELEPHONE NUMBER(S):

Daytime number/s: 0124206053

Afterhours number: 0845119226

Dear Prospective Participant

 

1)         INTRODUCTION

You are invited to volunteer for a research study. This information in this document is to help you to decide if you would like to participate. Before you agree to take part in this study you should fully understand what is involved. If you have any questions, which are not fully explained in this document, do not hesitate to ask the researcher. You should not agree to take part unless you are completely happy about all the procedures involved. 

 

2)         THE NATURE AND PURPOSE OF THIS STUDY

The aim of this study is to investigate the associated injuries risk factors among trial running race entrants of the 2023 Magoebas Forest Marathon. By doing so we wish to learn more about your demographics, training variables, sport participation, specific injuries/illness acquired before the race. We further want to determine baseline injury profiles of entrant of the 2022 Magoebas Forest Marathon.

 

3)         EXPLANATION OF PROCEDURES AND WHAT WILL BE EXPECTED FROM PARTICIPANTS.

This study involves answering some questions with regards to the 6 months prior to the race, examination of participation, performance and specific diagnosis that is associated with injuries will be evaluated.

 

 

4)         POSSIBLE RISKS AND DISCOMFORTS INVOLVED

There are no medical risks associated with the study.

 

 

5)         POSSIBLE BENEFITS OF THIS STUDY

Although you may or may not benefit directly. Once injury profiles and associated injury risk factors are better understood we can start implementing better injury risk management strategies to help make trail running races safer.

 

 

6)         YOUR RIGHTS AS A RESEARCH PARTICIPANT

Your participation in this trial is entirely voluntary and you can refuse to participate or stop at any time without stating any reason. Your withdrawal will not affect your access to other medical care.

 

 

8)          ETHICS APPROVAL

This protocol was approved by the Faculty of Health Sciences Research Ethics Committee, University of Pretoria, South Africa.

 

9)         INFORMATION

If I have any questions concerning this study, I should contact:

Carel Viljoen

Cell: 0845119226

Christa Janse van Rensburg

Work tel: 0124206053

 

10)       CONFIDENTIALITY

All information obtained during this study will be regarded as confidential. Each participant taking part will be provided with an alphanumeric coded number e.g. A001. This will ensure confidentiality of information so collected. Only the researcher will be able to identify you as a participant. Results will be published or presented in a way that patients remain unidentifiable. No hard copies of your records will be kept since this is an online questionnaire and the information will be stored on the Qualtrics platform.

 

11)       CONSENT TO PARTICIPATE IN THIS STUDY

  • I confirm that the person requesting my consent to take part in this study has told me about the nature and process, any risks or discomforts, and the benefits of the study.
  • I have also received, read and understood the above written information about the study.
  • I have had adequate time to ask questions and I have no objections to participate in this study.
  • I am aware that the information obtained in the study, including personal details, will be anonymously processed, and presented in the reporting of results.
  • I understand that I will not be penalised in any way should I wish to discontinue with the study and that withdrawal will not affect my further treatments.
  • I am participating willingly.
  • I have received a signed copy of this informed consent agreement.

 

At the end of the online questionnaire, you will be given the chance to give informed consent or not for the use of your data in the research study by clicking the appropriate answer.